The price of COVID-19 vaccines in the United States has increased drastically over the past several months, with the Centers for Disease Control and Prevention currently paying over $80 per dose for ...
In a March Congressional hearing on the vaccine's pricing, Moderna's CEO Stéphane Bancel—who became a billionaire during the ...
Investors have shied away from Moderna in recent times as demand for its one and only product -- the coronavirus vaccine -- declines. But that particular product could be the driving force behind ...
The company supplied its COVID vaccines to the EU during the pandemic, but the contract for its Omicron-adjusted vaccines ...
The CDC panel's vote comes after the FDA approved and authorized the new shots from Moderna and Pfizer on Monday, amid an increase in COVID hospitalizations and concern about the spread of several ...
Sept. 6, 2023 -- Moderna says its upcoming COVID-19 vaccine should work against the BA.2.86 variant that has caused worry about a possible surge in cases. “The company said its shot generated an ...
Moderna announced Wednesday that its updated coronavirus vaccine has been proven to offer a "strong human immune response" to a COVID-19 variant the CDC says "may be more capable" of infecting ...
Moderna CEO Stéphane Bancel told investors in August that the company expected its global COVID vaccine sales to be $6 billion to $8 billion this year, depending on uptake in the U.S. Pfizer ...
Moderna announced Wednesday that its updated COVID-19 vaccine is effective against emerging variants of the virus, including the Pirola variant. The XBB.1.5 variant, also referred to as Kraken, has ...
Moderna has pledged never to enforce its coronavirus vaccine patents in selected low- and middle-income countries and is launching a new initiative to give external researchers access to its ...
The Centers for Disease Control and Prevention on Tuesday recommended people 6 months and older receive an updated COVID vaccine to protect themselves against getting sick or hospitalized from the ...
Moderna said its experimental mRNA-based flu vaccine generated a stronger immune response against four strains of the virus than a currently available flu vaccine. The late-stage trial results ...
